Abstract
Cell-to-cell communication in the nervous system is brought about mainly by the exchange of chemical signals — the neurotransmitters or neuromodulators. A biological response is elicited by the interaction of these signals with highly selective receptors on target cells which discriminate between various neurotransmitters. Psychoactive drugs interfere in various ways with chemical signalling in the central nervous system, frequently producing their specific effects by interacting with distinct proteins or glycoproteins in the target ceil membrane — the pharmacological receptors (Ariëns, 1983; Snyder, 1984). The benzodiazepines are no exception.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albright, J. D., Moran, D. B., Wright, W. B., Collins, J. B., Beer, B., Lippa, A. S. and Greenblatt, E. N. (1981). Synthesis and anxiolytic activity of 6-(substituted-phenyl)-1,2, 4-triazolo (4,3-b)pyridazines. J. Med. Chem., 24, 592
Anderson, R. A. and Mitchell, R. (1983). Multiple benzodiazepine binding sites in rat pituitary. Br. J. Pharmacol., 79, 290P
Anderson, R. A. and Mitchell, R. (1984). Benzodiazepines potentiate the effect of muscimol on prolactin secretion in vitro. Br. J. Pharmacol., 82, 343P
Anholt, R. R., Murphy, K. M. M., Mack, G. and Snyder, S. H. (1984). Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J. Neurosci., 4, 593
Ari’ëns, E. J. (1983). Receptors: the materialization of a concept. Pharmac. Weekbl. Sci Ed., 5, 121
Barker, J. L., Gratz, E., Owen, D. G. and Study, R. E. (1984). In Bowery, N. G. (Ed.), Actions and Interactions of GABA and Benzodiazepines, pp. 203–216. Raven Press, New York
Barrnett, A., Billard, W. and Iorio, L. C. (1983). Studies on the specificity of halazepam, a benzodiazepine with reduced dependence liability. Fed. Proc., 42, 309
Battersby, M. K., Richards, J. G. and Möhler, H. (1979). Benzodiazepine receptor: photo-affinity labelling and localization. Europ. J. Pharmacol., 57, 277
Beaumont, K., Cheung, A. K., Geller, M. L. and Fanestil, D. D. (1983). Inhibitors of peripheral-type benzodiazepine receptors present in human urine and plasma ultrafiltrates. Life Sci., 33, 1375
Beaumont, K., Healy, D. P. and Fanestil, D. D. (1984). Peripheral-type benzodiazepine (BZD) receptors in the rat kidney: localization by autoradiography. Fed. Proc., 43, 691
Benavides, J., Malgouris, C., Imbault, F., Begassat, F., Uzan, A., Renault, C., Dubroeucq, D., Gueremy, C. and Le Fur, G. (1983a). ‘Peripheryl-type’ benzodiazepine binding sites in rat adrenals: binding studies with [3H]-PK 11195 and autoradiographic localization. Arch Int. Pharmacodyn., 266, 38
Benavides, J., Quarteronet, D., Imbault, F., Malgouris, C., Uzan, A., Renault, C., Dubroeucq, M.C., Gueremy, C. and Le Fur, G. (1983b). Labelling of ‘peripheryl-type’ benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem., 41, 1744
Biscoe, T. J. and Fry, J. P. (1984). Actions and Interactions of GABA and Benzodiazepines, pp. 217–237. Raven Press, New York
Blanchard, J. C., Boireau, A., Garret, C. and Julou, L. (1979). In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci., 24, 2417
Blount, J. F., Fryer, R. K., Gilman, N. W. and Todaro, L. J. (1973). Quinazolines and 1,4-benzodiazepines 92. Conformational recognition of the receptor by 1,4-benzodiazepines. Molec. Pharmacol., 24, 425
Bonetti, E. P., Pieri, L., Cumin, R., Schaffner, R., Pieri, M., Gamzu, E. R., Müller, R. K. M. and Haefely, W. (1982). Benzodiazepine antagonist Ro 15–1788: neurological and behavioural effects. Psychopharmacology, 78, 8
Bowery, N. G., Hill, D. R., Hudson, A. L., Price, G. W., Turnbull, M. J. and Wilkin, G. P. (1984). In Bowery, N. G. (Ed.), Actions and Interactions of GABA and Benzodiazepines, pp. 81–108. Raven Press, New York
Braestrup, C. and Nielsen, M. (1978). Ontogenetic development of benzodiazepine receptors in the rat brain. Brain Res., 147, 170
Braestrup C. and Nielsen, M. (1982). Neurotransmitters and CNS disease, anxiety. Lancet, ii, 1030
Braestrup, C. and Nielsen, M. (1983). In Iversen, L. L., Iversen, S. D. and Synder, S. H. (Eds.), Handbook of Psychopharmacology, Vol. 17, pp. 285–384. Plenum Press, New York
Braestrup, C., Nielsen, M. and Olsen, C. E. (1980). Urinary and brain β-carboline-3-carboxy-lates as potent inhibitors of brain benzodiazepine receptors. Proc. Natl. Acad. Sci U.S.A., 77, 2288
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M. and Petersen, E. N. (1982). Interaction of convulsive ligands with benzodiazepine receptors. Science, N. Y., 216, 1241
Braestrup, C. and Squires, R. F. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity 3H-diazepam binding. Proc. Natl. Acad. Sci. U.S.A., 74, 3805
Brown, C. L., Jones, B. J., Martin, I. L. and Oakley, N. R. (1984). Efficacy at the benzodiazepine receptor: in vivo studies with pyrazoloquinolinones. Br. J. Pharmacol, 82, 236P
Brown, C. L. and Martin, I. L. (1983). Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy. Neurosci. Lett., 35, 37
Brown, C. L. and Martin, I. L. (1984). Autoradiographic localization of benzodiazepine receptors in the rat pituitary gland. Europ. J. Pharmacol, 102, 563
Burnham, W. M., Niznik, H. B., Okazaki, M. M. and Kish, S. J. (1983). Binding of [3H]-flunitrazepam and [3H] Ro 5–4864 to crude homogenates of amygdala-kindled rat brain: two months post-seizure. Brain Res., 279, 359
Candy, J. M. and Martin, I. L. (1979). The postnatal development of the benzodiazepine receptor in the cerebral cortex and cerebellum of the rat. J. Neurochem., 32, 655
Chang, L.-R. and Barnard, E. A. (1982). The benzodiazepine/GABA receptor complex: molecular size in brain synaptic membrane and in solution. J. Neurochem., 39, 1507
Chang, R. S. L. and Snyder, S. H. (1978). Benzodiazepine receptors: labelling in intact animals with [3H]-flunitrazepam. Europ. J. Pharmacol., 48, 213
Clineschmidt, B. V., Martin, G. E. and Bunting, P. R. (1982). Anticonvulsant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Devl. Res., 2, 123
Comar, D., Mazière, M., Cepeda, C., Godot, J.-M., Menini, C. and Naquet, R. (1981). The kinetics and displacement of [11C]flunitrazepam in the brain of the living baboon. Europ. J. Pharmacol., 75, 21
Costa, E., Corda, M. G., Epstein, B., Forchetti, C. and Guidotti, A. (1983a). In Costa, E. (Ed.), The Benzodiazepines: From Molecular Biology to Clinical Practice, pp. 117–136. Raven Press, New York
Costa, E., Corda, M. G. and Guidotti, A. (1983b). On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives. Neuropharmacology, 22, 1481
Cumin, R., Bonetti, E. P., Scherschlicht, R. and Haefely, W. E. (1981). Use of the specific benzodiazepine antagonist, R.15-1788, in studies of physiological dependence on benzodiazepines. Experientia, 38, 833
Czernik, A. J., Petrack, B., Kalinsky, H. J., Psychoyos, St., Gash, W. D., Tsai, C., Rinehart, R. K., Garnat, F. R., Lovell, R. A., Brundish, D. E. and Wade, R. (1982). CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist. Life Sci., 30, 363
Darragh, A., Lambe, R., Brick, I. and O’Boyle, C. (1982). Antagonism of the central effects of 3-methyl-clonazepam. Br. J. Clin. Pharmacol., 14, 871
Davies, L. P. and Huston, V. (1981). Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Europ. J. Pharmacol., 73, 209
De Souza, E. B., Anholt, R. H., Murphy, K. M. M., Snyder, S. H. and Kuhar, M. J. (1985). Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal and testes. Endocrinology, 116, 567
Del Zompo, M., Bocchetta, A., Corsini, G. U., Tallman, J. F. and Gessa, G.L. (1983b). In Biggio, G. and Costa, E. (Eds), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 239–248. Raven Press, New York
Del Zompo, M., Post, R. M. and Tallman, J. F. (1983a). Properties of two benzodiazepine binding sites in spinal cord. Neuropharmacology, 22, 115
Dubnick, B., Lippa, A. S., Klepner, C. A., Coupet, J., Greenblatt, E. N. and Beer, B. (1983). The separation of 3H-benzodiazepine binding sites in brain and of benzodiazepine pharmacological properties. Pharmacol. Biochem. Behav., 18, 311
Ehlert, F. J., Ragan, P., Chen, A., Roeske, W. R. and Yamamura, H. I. (1982). Modulation of benzodiazepine receptor binding: insight into pharmacological efficacy. Europ. J. Pharmacol., 78, 249
Ehlert, F. J., Roeske, W. R., Gee, K. W. and Yamamura, H. I. (1983). An allosteric model for benzodiazepine receptor function. Biochem. Pharmacol., 32, 2375
Fallon, J. H., Loughlin, S. E. and Ribak, C. E. (1983). The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striato-pallidal system. J. Comp. Neurol., 218, 91
Ferrero, P., Guidotti, A. and Costa, E. (1984). Increase in the Bmax of γ-aminobutyric acid-A recognition sites in brain regions of mice receiving diazepam. Proc. Natl. Acad. Sci. U.S.A., 81, 2247
Fryer, R. I. (1983). In Costa, E. (Ed.), The Benzodiazepines: From Molecular Biology to Clinical Practice, pp. 7–20. Raven Press, New York
Gallager, D. W., Lakoski, J. M., Gonsalves, S. F. and Rauch, S. L. (1984a). Chronic benzodiazepine treatment decreases postsynaptic GAB A sensitivity. Nature, Lond., 308, 74
Gallager, D.W., Mallorga, P., Oertel, W., Henneberry, R. and Tallman, J. (1981). 3H-Diazepam binding in mammalian central nervous system: a pharmacological characterization. J. Neurosci., 1, 218
Gallager, D.W., Rauch, S. L. and Malcolm, A.B. (1984b). Alterations in a low affinity GABA recognition site following chronic benzodiazepine treatment. Europ. J. Pharmacol., 98, 159
Gee, K. W., Brinton, R. E. and Yamamura, H. I. (1983a). CL 218 872, PK 8165 and PK 9084: selective anxiolytics that may act as partial agonists at the benzodiazepine receptor. Fed. Proc., 42, 5096
Gee, K. W., Wamsley, J. K. and Yamamura, H. I. (1983b). Light microscopic autoradiographic identification of picrotoxin/barbiturate binding sites in rat brain with [35S] t-butyl-bicyclophosphothionate. Europ. J. Pharmacol., 89, 323
Gee, K. W. and Yamamura, H. I. (1983). In Biggio, G. and Costa, E. (Eds.), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 1–9. Raven Press, New York
Gehlert, D. R., Yamamura, H. I. and Wamsley, J. K. (1983). Autoradiographic localization of ‘peripheral’ benzodiazepine binding sites in the rat brain and kidney using [3H]Ro 5–4864. Europ. J. Pharmacol., 95, 329
Grandison, L. (1983). Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology, 22, 1505
Greenblatt, D. J., Shader, R. I. and Abernethy, D. R. (1983a). Current status of benzodiazepines (first of two parts). New Engl. J. Med., 309, 354
Greenblatt, D. J., Shader, R. I. and Abernethy, D. R. (1983b). Current status of benzodiazepines (second of two parts). New Engl. J. Med., 309, 410
Haefely, W. (1983). The biological basis of benzodiazepine actions. The benzodiazepines today — two decades of research and clinical experience. J. Psychoact. Drugs, 15, 19
Haefely, W. (1984). Pharmacological profile of two benzodiazepine partial agonists: Ro 16–6028 and Ro 17–1812. Clin. Neuropharmacol., Suppl. 1, 670
Haefely, W., Bonetti, E. P., Burkard, W. P., Cumin, R., Laurent, J.-P., Möhler, H., Pieri, L., Polc, P., Richards, J. G., Schaffner, R. and Scherschlicht, R. (1983a). In Costa, E. (Ed.), The Benzodiazepines: From Molecular Biology to Clinical Practice, pp. 137–146. Raven Press, New York
Haefely, W., Kyburz, E., Gerecke, M. and Möhler, H. (1984). Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationship of their agonists and antagonists. In Advances in Drug Research, Vol. 14, p. 166
Haefely, W., Pieri, L., Polc, P. and Schaffner, R. (1981). In Hoffmeister, F. and Stille, G. (Eds.), Handbook of Experimental Pharmacology, Vol. 55: Psychotropic Agents, Part II, pp. 13–262. Springer-Verlag, Berlin
Haefely, W., Polc, P., Pieri, L., Schaffner, R. and Laurent, J.-P. (1983b). In Costa, E. (Ed.), The Benzodiazepines: From Molecular Biology to Clinical Practice, pp. 21–66. Raven Press, New York
Hamor, T. A. and Martin, I. L. (1983). In Ellis, G. P. and West, G. B. (Eds.), Progr. Med. Chem., 20, 157
Häring, P., Stähli, C., Schoch, P., Takács, B., Staehelin, T. and Möhler, H. (1985). Monoclonal antibodies reveal structural homogeneity of GABAA/benzodiazepine receptors in different brain areas. Proc. Natl. Acad. Sci. U.S.A., 82, 4837
Honoré, T., Nielsen, M. and Braestrup, C. (1984). Barbiturate shift as a tool for determination of efficacy of benzodiazepine-receptor ligands. Europ. J. Pharmacol., 100, 103
Hunkeler, W., Möhler, H., Pieri, L., Bonetti, E. P., Cumin, R., Schaffner, R. and Haefely, W. (1981). Selective antagonists of benzodiazepines. Nature, Lond., 290, 514
Hunt, P., Husson, J.-M. and Raynaud, J.-P. (1979). A radioreceptor assay for benzodiazepines. J. Pharm. Pharmacol., 31, 448
Ishikawa, K., Watabe, S. and Goto, N. (1983). Laminal distribution of γ-aminobutyric acid (GABA) in the occipital cortex of rats: evidence as a neurotransmitter. Brain Res., 277, 361
Jaffé, E. H. and Cuello, A. C. (1981). Neuronal and glial release of [3H]-GABA from the rat olfactory bulb. J. Neurochem., 37, 1457
Karobath, M. and Sperk, G. (1979). Stimulation of benzodiazepine receptor binding by γ-amino-butyric acid. Proc. Natl. Acad. Sci. U.S.A., 76, 1004
Kish, S. J., Perry, T. L. and Hornykiewicz, O. (1984). Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. J. Neurochem., 42, 466
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. and Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol. Biochem. Behav., 11, 475
Kuhar, M. J. (1985). Receptor localization with the microscope. In Yamamura, H. I., Emma, S. J. and Kuhar, M. J. (Eds.), Neurotransmitter Receptor Binding, 2nd edn, pp. 153–176. Raven Press, New York
Laduron, P. M. (1984). Criteria for receptor sites in binding studies. Biochem. Pharmacol., 33, 833
Leeb-Lundberg, L. M. F. and Olsen, R.W. (1983). Heterogeneity of benzodiazepine receptor interactions with γ-aminobutyric acid and barbiturate receptor sites. Molec. Pharmacol., 23, 315
Le Fur, G., Mizoule, J., Burgevin, M. C. Ferris, O., Heaulme, M., Gauthier, A., Gueremy, C. and Uzan A. (1981). Multiple benzodiazepine receptors: evidence of a dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives). Life Sci., 28, 1439
Leonhardt, H. (1980). In Oksche, A. and Vollrath, L. (Eds.), Handbuch der mikroskopischen Anatomie des Menschen. 4. Band: Nervensystem, 10. Teil: Neuroglia I, pp. 177–666. Springer-Verlag, Berlin
Lippa, A. S., Beer, B., Sano, M. C., Vogel, R. A. and Meyerson, L. R. (1981). Differential ontogeny of type 1 and type 2 benzodiazepine receptors. Life Sci., 28, 2343
Lippa, A. S., Klepner, A., Benson, D. I., Critchett, D. J., Sano, M. C. and Beer, B. (1980). The role of GABA in mediating the anticonvulsant properties of benzodiazepines. Brain Res. Bull., 5 (Suppl. 2), 861
Lippa, A. S., Meyerson, L. R. and Beer, B. (1982). Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors. Life Sci., 31, 1409
Lo, M. M. S., Niehoff, D. L., Kuhar, M. J. and Snyder, S. H. (1983a). Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologie specificity. Neurosci. Lett., 39, 37
Lo, M. M. S., Niehoff, D. L., Kuhar, M. J. and Snyder, S. H. (1983b). Differential localization of type I and type II benzodiazepine binding sites in substantia nigra. Nature, Lond., 306, 57
Lo, M. M. S., Triffelletti, R. and Snyder, S. H. (1982). Physical separation and characterization of two central benzodiazepine receptors. In Paul, M.S. M., Tallman, J. and Usdin, E. (Eds.), Pharmacology of Benzodiazepines, pp. 165–173. Macmillan Press, London
Lowenstein, P. R. and Cardinali, D. P. (1983). Characterization of flunitrazepam and beta-carboline high affinity binding in bovine pineal gland. Neuroendocrinology, 37, 150
Lund, J. (1981). Radioreceptor assay for benzodiazepines in biological fluids using a new drug and stable receptor preparation. Scand. J. Clin. Lab. Invest., 41, 275
McCarthy, K. D. and Harden, T. K. (1981). Identification of two benzodiazepine binding sites on cells cultured from rat cerebral cortex. J. Pharmacol. Exp. Ther., 216, 183
MacNeil, D. A., D’Amico, J. A., Horst, W. D., O’Brien, R. A. and Spirt, N. (1983). Influences of 2 atypical benzodiazepines, Ro 5–3663 and Ro 5–4864, on GABAergic mechanisms. Soc. Neurosci., 9, 412
Mallorga, P., Hamburg, M., Tallman, J. and Gallager, D. (1980). Ontogenic changes in GABA modulation of brain benzodiazepine binding. Neuropharmacology, 19, 405
Marangos, P. J., Patel, J., Boulenger, J. P. and Clark-Rosenberg, R. (1982). Characterization of peripheral type benzodiazepine binding sites in brain using [3H]Ro 5–4864. Molec. Pharmacol., 22, 26
Marks, J. (1983). The benzodiazepines for good or evil. Neuropsychobiology, 10, 115
Martin, I. L., Brown, C. L. and Doble, A. (1983). Multiple benzodiazepine receptors: structures in the brain or structures in the mind? A critical review. Life Sci., 32, 1925
Mathew, E., Laskin, J. D., Zimmerman, E. A., Weinstein, I. B., Hsu, K. C. and Engelhardt, D. L. (1981). Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc. Natl Acad. Sci. U.S.A., 78, 3935
Mathew, E., Parfitt, A. G., Sugden, D., Engelhardt, D. L., Zimmerman, E. A. and Klein, D. C. (1984). Benzodiazepines: rat pinealocyte binding sites and augmentation of norepinephrine-stimulated N-acetyltransferase activity. J. Pharmacol. Exp. Ther., 228, 434
Mazière, M., Prenant, Ch., Sastre, J., Crouzet, M., Comar, D., Hantraye, P., Kaisima, M., Guibert, B. and Naquet, R. (1983). 11C-Ro 15–1788 et 11C-flunitrazepam, deux co-ordinats pour l’étude par tomographie par positrons des sites de liaison des benzodiazépines. C.R. Acad. Sci. Paris, 296 (Sér. III), 871
Medina, J. H., Novas, M. L. and De Robertis, E. (1983a). Chronic Ro 15–1788 treatment increases the number of benzodiazepine receptors in rat cerebral cortex and hippocampus. Europ. J. Pharmacol, 90, 125
Medina, J. H., Novas, M. L. and De Robertis, E. (1983b). Changes in benzodiazepine receptors by acute stress: different effect of chronic diazepam or Ro 15–1788 treatment. Europ. J. Pharmacol., 96, 181
Meiners, B. A. and Salama, A. L. (1982). Enhancement of benzodiazepine and GABA binding by the novel anxiolytic, tracazolate. Europ. J. Pharmacol., 78, 315
Meldrum, B. S., Evans, M. C. and Braestrup, C. (1983). Anticonvulsant action in the photosensitive baboon, Papio papio, of a novel β-carboline derivative, ZK 91296. Europ. J. Pharmacol., 91, 255
Mennini, T. and Garattini, S. (1983). In Biggio, G. and Costa, E. (Eds.), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 189–199. Raven Press, New York
Mestres, P. (1978). Old and new concepts about circumventricular organs; an overview. In Johari, O. and Becker, R. P. (Eds.), Scanning Electron Microscopy, Vol. II, pp. 137–142. SEM Inc. AMF O’Hare, Ill.
Minchin, M. C. W. and Nutt, D. J. (1983). Studies on [3H]diazepam and [3H]ethyl-β-carboline carboxylate binding to rat brain in vivo. I. Regional variations in displacement. J. Neurochem., 41, 1507
Möhler, H. (1982). Benzodiazepine receptors: differential interaction of benzodiazepine agonists and antagonists after photoaffinity labelling with flunitrazepam. Europ. J. Pharmacol., 80, 435
Möhler, H. (1984). In Bowery, N. G. (Ed.), Actions and Interactions of GABA and Benzodiazepines, pp. 155–166. Raven Press, New York
Möhler, H., Battersby, M. K. and Richards, J. G. (1980). Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc. Natl. Acad. Sci. U.S.A., 77, 1666
Möhler, H., Buikard, W. P., Keller, H. H., Richards, J. G. and Haefely, W. (1981b). Benzo-diazepine antagonist Ro 15–1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J. Neurochem., 37, 714
Möhler, H. and Okada, T. (1977). Benzodiazepine receptors: demonstration in the central nervous system. Science, N. Y., 198, 849
Mönier, H., Okada, T., Heitz, Ph. and Ulrich, J. (1978). Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci., 22, 985
Möhler, H. and Richards, J. G. (1981). Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature, Lond., 294, 763
Möhler, H. and Richards, J. G. (1983a). In Malick, J. B., Enna, S. J. and Yamamura, H. I. (Eds.), Anxiolytics: Neurochemical, Behavioural and Clinical Perspectives, pp. 15–40. Raven Press, New York
Möhler, H. and Richards, J. G. (1983b). Autoradiographic visualization and pharmacological characterization of 3H-Ro 5–4864 binding in the CNS. Br. J. Pharmacol., 79 (Suppl.), 280P
Möhler, H., Richards, J. G. and Wu, J.-Y. (1981a). Autoradiographic localization of benzodiazepine receptors in immunocytochemically identified γ-aminobutyrergic synapses. Proc. Natl. Acad. Sci. U.S.A., 78, 1935
Möhler, H., Schoch, P., Richards, J. G., Häring, P., Takàcs, B. and Stähli, C. (1986). Monoclonal antibodies as probes for studying the structure and location of the G AB A receptor/benzodiazepine receptor/chloride channel complex. In Olsen, R. W. and Ventner, J. C. (Eds.), Benzodiazepine-GABA Receptor and Chloride Channel. Alan R. Liss, New York, in press
Möhler, H., Sieghart, W., Richards, J. G. and Hunkeler, W. (1984). Photoaffinity labelling of benzodiazepine receptors with a partial inverse agonist. Europ. J. Pharmacol, 102, 191
Moingeon, Ph., Bidart, J. M., Alberici, G. F. and Bohuon, C. (1983). Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytes. Europ. J. Pharmacol., 92, 147
Mugnaini, E. and Oertel, W. H. (1985). An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In Björklund, A. and Hökfelt, T. (Eds.), Handbook of Chemical Neuroanatomy, Vol. 4: GABA and Neuro-peptides in the CNS, Part 1, pp. 436–595. Elsevier, Amsterdam
Myslobodsky, M., Feldon, J. and Lerner, T. (1983). Anticonflict action of sodium valproate, interaction with convulsant benzodiazepine (Ro 5–3663) and imidazodiazepine (Ro 15–1788). Life Sci., 33, 317
Niehoff, D. L., Mashal, R. D. and Kuhar, M. J. (1983). Benzodiazepine receptors: Preferential stimulation of type 1 receptors by pentobarbital. Europ. J. Pharmacol., 92, 131
Niehoff, D. L. and Whitehouse, P. J. (1983). Multiple benzodiazepine receptors: Autoradiographic localization in normal human amygdala. Brain Res., 276, 237
Nielsen, M. and Braestrup, C. (1980). Ethyl-β-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature, Lond., 286, 606
Nielsen, M., Braestrup, C. and Squires, R. F. (1978). Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Res., 141, 342
Niznik, H. B., Kish, S. J. and Burnham, W. M. (1983). Decreased benzodiazepine receptor binding in amygdala-kindled rat brains. Life Sci., 33, 425
Nutt, D. J., Cowen, P. J. and Little, H. J. (1981). Unusual interactions of benzodiazepine receptor antagonists. Nature, Lond., 295, 436
O’Boyle, C., Lambe, R., Darragh, A., Taffe, W., Brick, I. and Kenny, M. (1983). Ro 15–1788 antagonizes the effects of diazepam in man without affecting its bioavailability. Br. J. Anaesth., 55, 349
Oertel, W. H., Mugaini, E., Tappaz, M. L., Weise, V. K., Dahl, A.-L, Schmechel, D. E. and Kopin, I. J. (1982). Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat. Proc. Natl. Acad. Sci. U.S.A., 79, 675
Olsen, R. W. (1982). Drug interactions at the GABA receptor-ionophore complex. Ann. Rev. Pharmacol. Toxicol., 22, 245
Owen, F., Poulter, M., Waddington, J. L., Mashal, R. D. and Crow, T. J. (1983). [3H]Ro 5–4864 and [3H ] flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res., 278, 373
Palacios, J. M., Niehoff, D. L. and Kuhar, M. J. (1979). Ontogeny of GABA and benzodia-zepine receptors: effects of Triton X-100 and muscimol. Brain Res., 179, 390
Palacios, J. M., Niehoff, D. L. and Kuhar, M. J. (1981). Receptor autoradiography with 3H-sensitive film: potential for computerized densitometry. Neurosci. Lett., 25, 101
Palacios, J. M., Young, W. S. III and Kuhar, M. (1980). Autoradiographic localization of γ-aminobutyric acid (GABA) receptors in the rat cerebellum. Proc. Natl. Acad. Sci. U.S.A., 77, 670
Petrack, B., Czernik, A. J., Cassidy, J. P., Bernard, P. and Yokoyama, N. (1983). In Biggio, G. and Costa, E. (Eds.), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 129–137. Raven Press, New York
Pieri, L., Polc, P., Bonetti, E. P., Burkard, W. P., Cumin, R., Scherschlicht, R. and Haefely, W. (1983). Some pharmacological effects of Ro 5–4864, a specific ligand of the peripheral type of benzodiazepine binding sites. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharma-kol., 322, 5377
Polc, P., Bonetti, E. P., Schaffner, R. and Haefely, W. (1982). A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15–1788, benzodiazepine tranquilizers, β-carbolines and phenobarbitone. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol., 321, 260
Polc, P., Laurent, J.-P., Scherschlicht, R. and Haefely, W. (1981). Electrophysiological studies on the specific benzodiazepine antagonist Ro 15–1788. Naunyn-Schmiedebergs Arch. Exp. Pathol Pharmakol., 316, 317
Polc, P., Möhler, H. and Haefely, W. (1974). The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol., 284, 319
Polc, P. and Schaffner, R. (1983). Electrophysiological effects of the peripheral-type benzodiazepine receptor ligand Ro 5–4864 in cat spinal cord and rat hippocampus. Presented at 7th European Neuroscience Congress, Hamburg, 12–16 September
Prado de Carvalho, L., Venault, P., Cavalheiro, E., Kaijima, M., Valin, A., Dodd, R. H., Potier, P., Rossier, J. and Chapouthier, G. (1983). In Biggio, G. and Costa, E. (Eds.), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 175–187. Raven Press, New York
Rapold, H. J., Follath, F., Scollo-Lavizzari, G., Kehl, O. and Ritz, R. (1984). Verlängertes Koma durch Sedation mit Diazepam bei beatmeten Patienten. Diagnostische und therapeutische Anwendung des Benzodiazepin-Antagonisten Ro 15–1788. Dtsch. Med. Wschr., 109, 340
Regan, J. W., Roeske, W. R. and Yamamura, H. I. (1980). The benzodiazepine receptor: its development and its modulation by γ-aminobutyric acid. J. Pharmacol. Exp. Ther., 212, 137
Ribak, C. E., Vaughn, J. E. and Saito, K. (1978). Immunocytochemical localization of glutamic decarboxylase in neuronal somata following colchicine inhibition of axonal transport. Brain Res., 140, 315
Ribak, C. E., Vaughn, J. E., Saito, K., Barber, R. and Roberts, E. (1977). Glutamate decarboxylase localization in neurons of the olfactory bulb. Brain Res., 126, 1
Ribak, C. E., Vaughn, J. E., Saito, K., Barber, R. and Roberts, E. (1976). Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra. Brain Res., 116, 287
Richards, J. G. and Möhler, H. (1984a). Benzodiazepine receptors. Neuropharmacology, 23, 233
Richards, J. G. and Möhler, H. (1984b). Recent advances in the visualization and quantification of benzodiazepine receptors. In Agnati, L. F. and Fuxe, K. (Eds.), Quantitative Neuroanatomy in Transmitter Research, pp. 407–415. Macmillan Press, Basingstoke
Richards, J. G., Möhler, H. and Haefely, W. (1982). Benzodiazepine binding sites: receptors or acceptors? Trends Pharmacol. Sci., 3, 233
Richards, J. G., Möhler, H. and Haefely, W. (1986a). Mapping benzodiazepine receptors in the CNS by radiohistochemistry and immunohistochemistry. In Panula, P., Päivärintan, H. and Soinila, S. (Eds.), Neurohistochemistry Today, Alan R. Liss, New York, in press
Richards, J. G., Mönier, H., Schoch, P., Häring, P., Takács, B. and Stähli, Ch. (1984). The visualization of neuronal benzodiazepine receptors in the brain by autoradiography and immunohistochemistry. J. Receptor Res., 4, 657
Richards, J. G., Möhler, H., Schoch, P., Haring, P., Takács, B. and Stähli, Ch. (1984). The visualization of neuronal benzodiazepine receptors in the brain by autoradiography and immunohistochemistry. J. Receptor Res., 4, 657
Richards, J. G., Schoch, P., Möhler, H. and Haefely, W. (1986b). Benzodiazepine receptors resolved. Experientia, 42, 121
Roberts, E. (1978). In Garattini, S., Pujol, J. F. and Samanin, R. (Eds.), Interactions between Putative Neurotransmitters in the Brain, pp. 89–107. Raven Press, New York
Roeske, W. R. and Yamamura, H. I. (1982). Identification and characterization of a novel benzodiazepine binding site in heart, skeletal muscle and ileal muscle using the ligand [3H] Ro 5–4864. Clin. Res., 30, 18A
Ruffolo, R. R. (1982). Important concepts of receptor theory. J. Auton. Pharmacol., 2, 277
Schlumpf, M., Richards, J. G., Lichtensteiger, W. and Möhler, H. (1983). An autoradio-graphic study of the prenatal development of benzodiazepine binding sites in rat brain. J. Neurosci., 3, 1478
Schmidt, R. F., Vogel, M. E. and Zimmerman, M. (1967). Die Wirkung von Diazepam auf die präsynaptische Hemmung und andere Rückenmarksreflexe. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol., 258, 69
Schoch, P., Haring, P., Takács, B., Stähli, C. and Möhler, H. (1984). A GABA/benzodiazepine receptor complex from bovine brain: purification, reconstitution and immunological characterization. J. Receptor Res., 4, 189
Schoch, P., and Möhler, H. (1983). Purified benzodiazepine receptor retains modulation by GABA. Europ. J. Pharmacol., 95, 323
Schoch, P., Richards, J. G., Häring, P., Takács, B., Stähli, C., Staehelin, T., Haefely, W. and Möhler, H. (1985). Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature, Lond., 314, 168
Schoemaker, H., Boles, R. G., Horst, W. D. and Yamamura, H.I. (1983). Specific high affinity binding sites for [3H]Ro 5–4864 in rat brain and kidney. J. Pharmacol. Exp. Ther., 225, 61
Schoemaker, H., Morelli, M., Desmukh, P. and Yamamura, H. L. (1982). [3H] Ro 54864 benzodiazepine binding in the kainate lesioned striatum and Huntington’s diseased basal ganglia. Brain Res., 248, 396
Scollo-Lavizzari, G. (1983). First clinical investigation of the benzodiazepine antagonist Ro 15–1788 in comatose patients. Europ. Neurol, 22, 7
Sher, P. K. (1983). Reduced benzodiazepine receptor binding in cerebral cortical cultures chronically exposed to diazepam. Epilepsia, 24, 313
Sher, P. K., Study, R. E., Mazzetta, J., Barker, J. L. and Nelson, P. G. (1983). Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam. Brain Res., 268, 171
Sieghart, W. (1983). Several new benzodiazepines selectively interact with a benzodiazepine receptor subtype. Neurosci. Lett., 38, 73
Sieghart, W. and Drexler, G. (1983). Irreversible binding of [3H]flunitrazepam to different proteins in various brain regions. J. Neurochem., 41, 47
Sieghart, W. and Karobath, M. (1980). Molecular heterogeneity of benzodiazepine receptors. Nature, Lond., 286, 285
Sieghart, W. and Mayer, A. (1982). Postnatal development of proteins irreversibly labelled by 3H-flunitrazepam. Neurosci Lett., 31, 71
Sigel, E., Stephenson, F. A., Mamalki, C. and Barnard, E. A. (1983). A γ-amino-butyric acid/benzodiazepine receptor complex of bovine cerebral cortex: purification and partial characterization. J. Biol Chem., 258, 6965
Sigel, E, Stephenson, F. A., Mamalaki, C. and Barnard, E. A. (1984). The purified GABA/benzodiazepine/barbiturate receptor complex: four types of ligand-binding sites, and the interactions between them, are preserved in a single isolated protein complex. J. Receptor Res., 4, 175
Simmonds, R. D., Kellogg, C. K. and Miller, R. K. (1984). Prenatal diazepam exposure in rats long-lasting, receptor-mediated effects on hypothalamic norepinephrine-containing neurons. Brain Res., 293, 73
Skerritt, J. H. and Johnston, G. A. R. (1983). Enhancement of GABA binding by benzodi-azepines and related anxiolytics. Europ. J. Pharmacol., 89, 193
Skolnick, P., Lock, K.-L., Paugh, B., Marangos, P., Windsor, R. and Paul, S. (1980). Pharmacologic and behavioral effects of EMD 28422: a novel purine which enhances (3H) diazepam binding to brain benzodiazepine receptors. Pharmacol. Biochem. Behav., 12, 685
Skolnick, P., Paul, S., Crawley, J., Lewin, E., Lippa, A., Clody, D., Irmscher, K., Saiko, O. and Minck, K.-O. (1983). Antagonism of the anxiolytic action of diazepam and chlor-diazepoxide by the novel imidazopyridines, EMD 39593 and EMD 41717. Europ. J. Pharmacol., 88, 319
Snyder, H. S. (1984). Drug and neurotransmitter receptors in the brain. Science, N. Y., 224, 22
Squires, F. R. (1983). Benzodiazepine receptor multiplicity. Neuropharmacology, 22, 1443
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Kiepner, C. A., Myers, V. and Beer, B. (1979). Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol. Biochem. Behav., 10, 825
Squires, R. F. and Braestrup, C. (1977). Benzodiazepine receptors in rat brain. Nature, Lond., 266, 732
Squires, R. F., Casida, J. E., Richardson, M. and Saederup, E. (1983). 35S-t-Butylbicyclo-phosphothionate binds with high affinity to brain specific sites coupled to GABAA and ion recognition sites. Molec. Pharmacol., 23, 326
Stephens, D. N., Kehr, W., Schneider, H. H. and Schmiechen, R. (1984). β-Carbolines with agonistic and inverse agonistic properties at benzodiazepine receptors of the rat. Neurosci. Lett., 47, 333
Sternberger, L. A. (1979). Immunocytochemistry, 2nd edn. Wiley, New York
Strittmatter, W. J., Hirata, F., Axelrod, J., Mallorga, P., Tallman, J. F. and Henneberry, R. C. (1979). Benzodiazepine and β-adrenergic receptor ligands independently stimulate phospholipid methylation. Nature, Lond., 2812, 857
Study, R. E. and Barker, J. L. (1982). Cellular mechanisms of benzodiazepine action. J. Am. Med. Ass., 247, 2147
Supavilai, P. and Karobath, M. (1981). Action of pyrazolopyridines as modulators of [3H ]flunitrazepam binding to the GABA/benzodiazepine receptor complex of the cerebellum. Europ. J. Pharmacol., 70, 183
Supavilai, P. and Karobath, M. (1983). Differential modulation of [35S]TBPS binding by the occupancy of benzodiazepine receptors with its ligands. Europ. J. Pharmacol., 91, 145
Syapin, P. J. and Skolnick, P. (1979). Characterization of benzodiazepine binding sites in cultured cells of neural origin. J. Neurochem., 32, 1047
Tallman, J. F., Thomas, J. W. and Gallager, D. W. (1978). GABAergic modulation of benzodiazepine binding site sensitivity. Nature, Lond., 274, 384
Taniguchi, T., Wang, J. K. T. and Spector, S. (1980). Properties of [3H]-diazepam binding to rat peritoneal mast cells. Life Sci., 27, 171
Thomas, J. W. and Tallman, J. F. (1981). Characterization of photoaffinity labeling of benzodiazepine binding. J Biol. Chem., 256, 9838
Thomas, J. W. and Tallman, J. F. (1983). Photoaffinity labeling of benzodiazepine receptors causes altered agonist-antagonist interactions. J. Neurosci., 3, 433
Ticku, M. K. (1983). Benzodiazepine-GABA receptor-ionophore complex. Current concepts. Neuropharmacology, 22, 1459
Ticku, M. K. and Ramanjaneyulu, R. (1984). Ro 5–4864 inhibits the binding of [35S]-t-butylbicyclophosphorothionate to rat brain membranes. Life Sci., 34, 631
Unnerstall, J. R., Kuhar, M. J., Niehoff, D. L. and Palacios, J. M. (1981). Benzodiazepine receptors are coupled to a subpopulation of γ-aminobutyric acid (GABA) receptors: evidence from a quantitative autoradiographic study. J. Pharmacol. Exp. Ther., 218, 797
Unnerstall, J. R., Niehoff, D. L., Kuhar, M. J. and Palacios, J. M. (1982). Quantitative receptor autoradiography using [3H]ultrofilm: application to multiple benzodiazepine receptors. J. Neurosci Meth., 6, 59
Villiger, J.W. (1984). Specific [3H]Ro 5–4864 binding to rat spinal cord membranes: evidence for peripheral type benzodiazepine recognition sites. Neurosci. Lett., 46, 267
Wamsley, J. K., Gee, K. W. and Yamamura, H. I. (1983). Comparison of the distribution of convulsant/barbiturate and benzodiazepine receptors using light microscopic auto-radiography. Life Sci., 33, 2321
Wamsley, J. K. and Palacios, J. M. (1982). In Lajtha, A. (Ed.), Handbook of Neurochemistry, 2nd edn, Vol. 2, pp. 27–51, Plenum Press, New York
Wang, J. K. T., Taniguchi, T. and Spector, S. (1980). Properties of [3H]-diazepam binding to rat blood platelets. Life Sci., 27, 1881
Wang, J. K. T., Taniguchi, T. and Spector, S. (1984). Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Molec. Pharmacol., 25, 349
Waszczak, B. L. (1983). Diazepam potentiates GABA-, but not adenosine-mediated inhibition of neurons of the nigral pars reticulata. Neuropharmacology, 22, 953
Weissman, B. A., Cott, J., Hommer, D., Paul, S. and Skolnick, P. (1984a). Electrophysio-logical and pharmacological actions of the convulsant benzodiazepine Ro 54864. Europ. J. Pharmacol., 97, 257
Weissman, B. A., Cott, J., Hommer, D., Quirion, R., Paul, S. and Skolnick, P. (1983). In Biggio, G. and Costa, E. (Eds.), Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 139–151. Raven Press, New York
Weissman, B. A., Cott, J., Jackson, J. A., Bolger, G. T., Weber, K. H., Horst, W. D., Paul, S. M. and Skolnick, P. (1984b). ‘Peripheral-type’ binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5–4864. J. Neurochem., 44, 1494
Williams, M. and Risley, E. A. (1979). Enhancement of the binding of 3H-diazepam to rat brain membranes in vitro by SQ 20009, a novel anxiolytic, γ-aminobutyric acid (GABA) and muscimol. Life Sci., 24, 833
Williamson, M. J., Paul, S. M. and Skolnick, P. (1978). Demonstration of [3H]diazepam binding to benzodiazepine receptors in vivo. Life Sci., 23, 1935
Wong, D. T., Threlkeld, P. G., Bymaster, F. P. and Squires, R. F. (1984). Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with GABAergic agents. Life Sci., 34, 853
Yokoyama, N., Ritter, B. and Neubert, A. D. (1982). 2-Arylpyrazolo (4,3-c) quinolin-3-ones: novel agonists, partial agonists and antagonists of benzodiazepines. J. Med. Chem., 25, 337
Young, W. S. and Kuhar, M. J. (1979). A new method for receptor autoradiography: [3H] opioid receptors in rat brain. Brain Res., 179, 255
Young, W. S. and Kuhar, M. J. (1980). Radiohistochemical localization of benzodiazepine receptors in rat brain. J. Pharmacol. Exp. Ther., 212, 337
Young, W. S., Niehoff, D., Kuhar, M. J., Beer, B. and Lippa, A. S. (1981). Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. J. Pharmacol. Exp. Ther., 216, 425
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1986 The Editor and the Contributors
About this chapter
Cite this chapter
Richards, G., Möhler, H., Haefely, W. (1986). Benzodiazepine Receptors and their Ligands. In: Woodruff, G.N. (eds) Mechanisms of Drug Action. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-08026-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-08026-7_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-08028-1
Online ISBN: 978-1-349-08026-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)